Efficient cell culture system for hepatitis C virus genotype 2B: Patent #: 8,663,653

Judith Margarete Gottwein; Maria Lisa Knudsen; Troels Kasper Hoyer  Scheel; Jens Bukh

Efficient cell culture system for hepatitis C virus genotype 2B: Patent #: 8,663,653

Judith Margarete Gottwein (Opfinder), Maria Lisa Knudsen (Opfinder), Troels Kasper Hoyer Scheel (Opfinder), Jens Bukh (Opfinder)

Abstract

The present inventors developed hepatitis C virus 2b/2a intergenotypic recombinants in which the JFH1 structural genes (Core, E1 and E2), p7 and the complete NS2 were replaced by the corresponding genes of the genotype 2b reference strain J8. Sequence analysis of recovered 2b/2a recombinants from 2 transfection experiments revealed that 2b/2a was genetically stable. Conclusion: The developed 2b/2a viruses provide a robust in vitro tool for research in HCV genotype 2b, including vaccine studies and functional analysis.

Originalsprog	Engelsk
IPC	A61K 39/12 (20060101); A61K 39/29 (20060101); C12N 1/20 (20060101); C12N 5/071 (20100101); C12N 15/00 (20060101); C12Q 1/70 (20060101)
Patentnummer	WO2010/017818
Journaliseringsdato	18/02/2010
Land/Område	Danmark
Prioritetsdato	24/07/2009
Prioritetsnummer	PCT/DK2009/050189
Status	Udgivet - 31 mar. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@misc{f58b685769cf4df885ffca2d50607cba,

title = "Efficient cell culture system for hepatitis C virus genotype 2B: Patent #: 8,663,653 ",

abstract = "The present inventors developed hepatitis C virus 2b/2a intergenotypic recombinants in which the JFH1 structural genes (Core, E1 and E2), p7 and the complete NS2 were replaced by the corresponding genes of the genotype 2b reference strain J8. Sequence analysis of recovered 2b/2a recombinants from 2 transfection experiments revealed that 2b/2a was genetically stable. Conclusion: The developed 2b/2a viruses provide a robust in vitro tool for research in HCV genotype 2b, including vaccine studies and functional analysis.",

author = "Gottwein, {Judith Margarete} and Knudsen, {Maria Lisa} and Scheel, {Troels Kasper Hoyer} and Jens Bukh",

year = "2014",

month = mar,

day = "31",

language = "English",

type = "Patent",

note = "WO2010/017818; A61K 39/12 (20060101); A61K 39/29 (20060101); C12N 1/20 (20060101); C12N 5/071 (20100101); C12N 15/00 (20060101); C12Q 1/70 (20060101)",

}

TY - PAT

T1 - Efficient cell culture system for hepatitis C virus genotype 2B

T2 - Patent #: 8,663,653

AU - Gottwein, Judith Margarete

AU - Knudsen, Maria Lisa

AU - Scheel, Troels Kasper Hoyer

AU - Bukh, Jens

PY - 2014/3/31

Y1 - 2014/3/31

N2 - The present inventors developed hepatitis C virus 2b/2a intergenotypic recombinants in which the JFH1 structural genes (Core, E1 and E2), p7 and the complete NS2 were replaced by the corresponding genes of the genotype 2b reference strain J8. Sequence analysis of recovered 2b/2a recombinants from 2 transfection experiments revealed that 2b/2a was genetically stable. Conclusion: The developed 2b/2a viruses provide a robust in vitro tool for research in HCV genotype 2b, including vaccine studies and functional analysis.

AB - The present inventors developed hepatitis C virus 2b/2a intergenotypic recombinants in which the JFH1 structural genes (Core, E1 and E2), p7 and the complete NS2 were replaced by the corresponding genes of the genotype 2b reference strain J8. Sequence analysis of recovered 2b/2a recombinants from 2 transfection experiments revealed that 2b/2a was genetically stable. Conclusion: The developed 2b/2a viruses provide a robust in vitro tool for research in HCV genotype 2b, including vaccine studies and functional analysis.

M3 - Patent

M1 - WO2010/017818

Y2 - 2010/02/18

ER -

Efficient cell culture system for hepatitis C virus genotype 2B: Patent #: 8,663,653

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater